vs

Side-by-side financial comparison of Inogen Inc (INGN) and Origin Bancorp, Inc. (OBK). Click either name above to swap in a different company.

Origin Bancorp, Inc. is the larger business by last-quarter revenue ($104.0M vs $68.6M, roughly 1.5× Inogen Inc). Over the past eight quarters, Inogen Inc's revenue compounded faster (4.2% CAGR vs 3.9%).

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

Southern Bancorp is a community development financial institution headquartered in Arkadelphia, Arkansas. It was founded in 1986 as Southern Development Bancorporation, and is often referred to simply as "Southern".

INGN vs OBK — Head-to-Head

Bigger by revenue
OBK
OBK
1.5× larger
OBK
$104.0M
$68.6M
INGN
Faster 2-yr revenue CAGR
INGN
INGN
Annualised
INGN
4.2%
3.9%
OBK

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
INGN
INGN
OBK
OBK
Revenue
$68.6M
$104.0M
Net Profit
$27.7M
Gross Margin
51.4%
Operating Margin
-13.6%
Net Margin
26.6%
Revenue YoY
3.4%
Net Profit YoY
EPS (diluted)
$-0.26
$0.89

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INGN
INGN
OBK
OBK
Q1 26
$104.0M
Q4 25
$68.6M
$103.4M
Q3 25
$79.1M
$109.8M
Q2 25
$79.2M
$83.5M
Q1 25
$68.5M
$94.1M
Q4 24
$66.3M
$78.3M
Q3 24
$74.9M
$90.8M
Q2 24
$74.4M
$96.4M
Net Profit
INGN
INGN
OBK
OBK
Q1 26
$27.7M
Q4 25
$29.5M
Q3 25
$-5.3M
$8.6M
Q2 25
$-4.2M
$14.6M
Q1 25
$-6.2M
$22.4M
Q4 24
$14.3M
Q3 24
$-6.0M
$18.6M
Q2 24
$-5.6M
$21.0M
Gross Margin
INGN
INGN
OBK
OBK
Q1 26
Q4 25
51.4%
Q3 25
52.2%
Q2 25
52.2%
Q1 25
53.1%
Q4 24
54.7%
Q3 24
55.2%
Q2 24
57.4%
Operating Margin
INGN
INGN
OBK
OBK
Q1 26
Q4 25
-13.6%
36.2%
Q3 25
-9.0%
10.0%
Q2 25
-7.7%
22.3%
Q1 25
-11.2%
30.4%
Q4 24
-17.2%
23.0%
Q3 24
-10.4%
26.1%
Q2 24
-9.5%
27.7%
Net Margin
INGN
INGN
OBK
OBK
Q1 26
26.6%
Q4 25
28.5%
Q3 25
-6.7%
7.9%
Q2 25
-5.2%
17.5%
Q1 25
-9.0%
23.8%
Q4 24
18.2%
Q3 24
-8.0%
20.5%
Q2 24
-7.5%
21.8%
EPS (diluted)
INGN
INGN
OBK
OBK
Q1 26
$0.89
Q4 25
$-0.26
$0.95
Q3 25
$-0.20
$0.27
Q2 25
$-0.15
$0.47
Q1 25
$-0.25
$0.71
Q4 24
$-0.41
$0.45
Q3 24
$-0.25
$0.60
Q2 24
$-0.24
$0.67

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INGN
INGN
OBK
OBK
Cash + ST InvestmentsLiquidity on hand
$103.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$192.2M
$1.3B
Total Assets
$298.6M
$10.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INGN
INGN
OBK
OBK
Q1 26
Q4 25
$103.7M
$424.2M
Q3 25
$106.5M
$626.9M
Q2 25
$103.7M
$334.1M
Q1 25
$118.9M
$486.2M
Q4 24
$113.8M
$470.2M
Q3 24
$105.7M
$321.2M
Q2 24
$97.9M
$288.1M
Stockholders' Equity
INGN
INGN
OBK
OBK
Q1 26
$1.3B
Q4 25
$192.2M
$1.2B
Q3 25
$197.2M
$1.2B
Q2 25
$199.5M
$1.2B
Q1 25
$198.0M
$1.2B
Q4 24
$173.9M
$1.1B
Q3 24
$185.4M
$1.1B
Q2 24
$187.6M
$1.1B
Total Assets
INGN
INGN
OBK
OBK
Q1 26
$10.2B
Q4 25
$298.6M
$9.7B
Q3 25
$307.0M
$9.8B
Q2 25
$312.0M
$9.7B
Q1 25
$308.4M
$9.8B
Q4 24
$296.2M
$9.7B
Q3 24
$306.2M
$10.0B
Q2 24
$308.9M
$9.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INGN
INGN
OBK
OBK
Operating Cash FlowLast quarter
$-943.0K
Free Cash FlowOCF − Capex
$-1.9M
FCF MarginFCF / Revenue
-2.8%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-13.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INGN
INGN
OBK
OBK
Q1 26
Q4 25
$-943.0K
$158.9M
Q3 25
$2.2M
$59.3M
Q2 25
$4.3M
$20.6M
Q1 25
$-16.8M
$35.6M
Q4 24
$-3.0M
$108.5M
Q3 24
$7.0M
$39.6M
Q2 24
$6.7M
$11.9M
Free Cash Flow
INGN
INGN
OBK
OBK
Q1 26
Q4 25
$-1.9M
$151.1M
Q3 25
$1.6M
$56.8M
Q2 25
$3.7M
$19.6M
Q1 25
$-17.1M
$34.8M
Q4 24
$-3.3M
$86.4M
Q3 24
$5.3M
$32.2M
Q2 24
$6.6M
$6.5M
FCF Margin
INGN
INGN
OBK
OBK
Q1 26
Q4 25
-2.8%
146.0%
Q3 25
2.0%
51.7%
Q2 25
4.6%
23.5%
Q1 25
-24.9%
37.0%
Q4 24
-5.0%
110.3%
Q3 24
7.1%
35.5%
Q2 24
8.9%
6.8%
Capex Intensity
INGN
INGN
OBK
OBK
Q1 26
Q4 25
1.4%
7.6%
Q3 25
0.7%
2.3%
Q2 25
0.9%
1.2%
Q1 25
0.4%
0.8%
Q4 24
0.5%
28.1%
Q3 24
2.2%
8.1%
Q2 24
0.1%
5.6%
Cash Conversion
INGN
INGN
OBK
OBK
Q1 26
Q4 25
5.38×
Q3 25
6.88×
Q2 25
1.41×
Q1 25
1.59×
Q4 24
7.60×
Q3 24
2.13×
Q2 24
0.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

OBK
OBK

Net Interest Income$87.2M84%
Noninterest Income$16.8M16%

Related Comparisons